ClinicalTrials.Veeva

Menu

Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY) (Clarity)

University of Oklahoma (OU) logo

University of Oklahoma (OU)

Status

Not yet enrolling

Conditions

Cigar Smoking
Tobacco Use

Treatments

Other: Cigarillo brand 3
Other: Cigarillo brand 2
Other: Cigarillo brand 1

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07162935
Clarity
R01DA062632-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This clinical trial will recruit young adults who currently use cigarillos and examine the smoking behavior and perceptions of different flavored cigarillos, product ingredients/additives impacting these perceptions, and simulated tobacco use outcomes (quitting, switching) in various policy scenarios where different types of flavors are available on the market.

Full description

This clinical trial will isolate the unique effects of concept descriptors on increased cigarillo use and appeal among experienced young adult cigarillo users. The study will seek to determine the addiction potential of concept flavored cigarillos by examining associations of cigarillo flavor type (concept, characterizing, tobacco) and cigarillo flavoring additives/ingredients to complementary measures of product appeal: subjective effects (e.g., satisfaction, reward, taste), actual smoking behavior (e.g., number of puffs), and simulated cigarillo purchasing, other tobacco product substitution, or quitting under different flavor ban scenarios via an Experimental Tobacco Marketplace (ETM).

Enrollment

300 estimated patients

Sex

All

Ages

18 to 24 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Ages 18 to 24
  2. Report past 30-day use of a cigarillo
  3. Ability to read English at least an 8th grade level
  4. No immediate plans to quit using tobacco
  5. At least 1 prior experience with a flavored tobacco product
  6. U.S. Citizen or permanent resident of the United States.

Exclusion criteria

  1. Current use of smoking cessation pharmacotherapy or nicotine replacement therapy;
  2. Pregnant, planning to become pregnant, or currently breastfeeding;
  3. Past or current clinically significant heart disease or hypertension, or other smoking-related disease that could preclude successful study completion;
  4. Inability to abstain from nicotine/tobacco products for at least 12 hours
  5. Unwillingness to use the research cigarillos in the lab

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

300 participants in 3 patient groups

Concept flavor
Experimental group
Description:
Participants will be randomized to smoke one of the three assigned concept flavored cigarillos
Treatment:
Other: Cigarillo brand 1
Other: Cigarillo brand 2
Other: Cigarillo brand 3
Characterizing flavor
Experimental group
Description:
Participants will be randomized to smoke one of the three assigned characterizing flavored cigarillos
Treatment:
Other: Cigarillo brand 1
Other: Cigarillo brand 2
Other: Cigarillo brand 3
Tobacco flavor
Experimental group
Description:
Participants will be randomized to smoke a tobacco flavored cigarillo
Treatment:
Other: Cigarillo brand 1
Other: Cigarillo brand 2
Other: Cigarillo brand 3

Trial contacts and locations

1

Loading...

Central trial contact

Project Manager

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems